Exoskeleton-assisted gait training for stroke rehabilitation
Effects of Exoskeleton-Assisted Gait Training on Functional Rehabilitation Outcomes in Patients With Stroke
This study is testing whether using a robotic exoskeleton during walking therapy can help stroke survivors recover better than regular walking exercises.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | All |
| Sponsor | University of Oklahoma Academic / other |
| Locations | 1 site (Oklahoma City, Oklahoma) |
| Trial ID | NCT03980457 on ClinicalTrials.gov |
What this trial studies
This study aims to evaluate the effectiveness of electromechanical exoskeleton-assisted gait training on rehabilitation outcomes for patients recovering from stroke. Conducted at the Oklahoma City VA Medical Center, it involves 50 patients who will receive standard therapy alongside either exoskeleton training or traditional over-ground gait training. The study will measure various functional outcomes, including independence and mobility, using established scales and assessments. Participants will be randomly assigned to either the experimental or control group, ensuring a robust comparison of the two approaches.
Who should consider this trial
Good fit: Ideal candidates are patients with acute ischemic or hemorrhagic stroke who are medically stable and able to stand independently.
Not a fit: Patients who are aphasic, confused, or medically unstable will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly enhance rehabilitation outcomes and mobility for stroke patients.
How similar studies have performed: Previous studies have shown promise in using exoskeletons for rehabilitation, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. All patients with acute hemorrhagic or ischemic stroke documented clinically and by neuroimaging. 2. Medically stable from a cardio-respiratory stand point so that they can participate in daily therapies. 3. Depressed patients will be included in the study 4. Patients able to stand alone 5. Patients able to provide a written informed consent, from cognitively intact patients (admission Mini Mental Scale Examination \[MMSE\] greater than or equal to 21). Exclusion Criteria: 1. Aphasic patients unable to communicate 2. Confused patients 3. Patients medically unstable 4. Patients unable to stand alone 5. Refusal to provide written informed consent
Where this trial is running
Oklahoma City, Oklahoma
- Oklahoma City VA Health Care System — Oklahoma City, Oklahoma, United States (Recruiting)
Study contacts
- Principal investigator: Meheroz H Rabadi, MD, MRCPI — Affiliate; Oklahoma VA Health Care System
- Study coordinator: Meheroz H Rabadi, MD, MRCPI
- Email: rabadimh@gmail.com
- Phone: 405-456-5298
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.